questionsmedicales.fr
Environnement et santé publique
Environnement
Mouvements de l'eau
Mouvements de l'eau : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Déshydratation
Évaluation clinique
Équilibre hydrique
Tests de laboratoire
Déséquilibre électrolytique
Analyse sanguine
Urgence médicale
Confusion
Symptômes
5
Surcharge hydrique
Essoufflement
Déséquilibre hydrique
Fatigue
Choc hypovolémique
Confusion mentale
Prévention
5
Déshydratation
Prévention
Surcharge hydrique
Surveillance
Équilibre hydrique
Alimentation
Déséquilibre électrolytique
Alimentation équilibrée
Traitements
5
Déshydratation
Hydratation orale
Surcharge hydrique
Diurétiques
Déséquilibre électrolytique
Suppléments
Hyperhydratation
Diurétiques
Choc hypovolémique
Fluides intraveineux
Complications
5
Déshydratation
Lésions rénales
Surcharge hydrique
Œdème pulmonaire
Déséquilibre électrolytique
Arythmies cardiaques
Hyperhydratation
Œdème cérébral
Choc hypovolémique
Défaillance multi-organique
Facteurs de risque
5
Déshydratation
Facteurs de risque
Surcharge hydrique
Insuffisance cardiaque
Déséquilibre électrolytique
Diurétiques
Hyperhydratation
Comportements à risque
Choc hypovolémique
Hémorragies
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Mouvements de l'eau : Questions médicales les plus fréquentes",
"headline": "Mouvements de l'eau : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Mouvements de l'eau : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-24",
"dateModified": "2025-02-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Mouvements de l'eau"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Environnement",
"url": "https://questionsmedicales.fr/mesh/D004777",
"about": {
"@type": "MedicalCondition",
"name": "Environnement",
"code": {
"@type": "MedicalCode",
"code": "D004777",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.230"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Mouvements de l'eau",
"alternateName": "Water Movements",
"code": {
"@type": "MedicalCode",
"code": "D014872",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ryan S Wagner",
"url": "https://questionsmedicales.fr/author/Ryan%20S%20Wagner",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology, Bowling Green State University, Bowling Green, OH, United States."
}
},
{
"@type": "Person",
"name": "Katelyn M McKindles",
"url": "https://questionsmedicales.fr/author/Katelyn%20M%20McKindles",
"affiliation": {
"@type": "Organization",
"name": "Great Lakes Center for Fresh Waters and Human Health, Bowling Green State University, Bowling Green, OH, United States."
}
},
{
"@type": "Person",
"name": "George S Bullerjahn",
"url": "https://questionsmedicales.fr/author/George%20S%20Bullerjahn",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology, Bowling Green State University, Bowling Green, OH, United States."
}
},
{
"@type": "Person",
"name": "Miguel A Gonzalez",
"url": "https://questionsmedicales.fr/author/Miguel%20A%20Gonzalez",
"affiliation": {
"@type": "Organization",
"name": "Universidad Rey Juan Carlos, ESCET, Mostoles, 28933 Madrid, Spain."
}
},
{
"@type": "Person",
"name": "Alberto Zaragoza",
"url": "https://questionsmedicales.fr/author/Alberto%20Zaragoza",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, The University of Utah, Salt Lake City, Utah 84112-0850, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Proprotein convertase subtilisin/kexin type 9 (PCSK9) in the central nervous system.",
"datePublished": "2023-04-03",
"url": "https://questionsmedicales.fr/article/37019248",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.neubiorev.2023.105155"
}
},
{
"@type": "ScholarlyArticle",
"name": "Real-World Outcomes of Proprotein Convertase Subtilisin Kexin-9 Inhibitor Use.",
"datePublished": "2023-05-01",
"url": "https://questionsmedicales.fr/article/36795508",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/FJC.0000000000001404"
}
},
{
"@type": "ScholarlyArticle",
"name": "Assessment of serum proprotein convertase subtilisin/kexin type 9 in pediatric sepsis syndrome.",
"datePublished": "2024-07-07",
"url": "https://questionsmedicales.fr/article/38972879",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-65609-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Safety of proprotein convertase subtilisin/kexin 9 inhibitors: a systematic review and meta-analysis.",
"datePublished": "2022-07-27",
"url": "https://questionsmedicales.fr/article/35508401",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/heartjnl-2021-320556"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association between proprotein convertase subtilisin/kexin type 9 and subclinical cerebrovascular disease in the community.",
"datePublished": "2023-02-16",
"url": "https://questionsmedicales.fr/article/36727585",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/ene.15723"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Environnement",
"item": "https://questionsmedicales.fr/mesh/D004777"
},
{
"@type": "ListItem",
"position": 4,
"name": "Mouvements de l'eau",
"item": "https://questionsmedicales.fr/mesh/D014872"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Mouvements de l'eau - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Mouvements de l'eau",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Mouvements de l'eau",
"description": "Comment diagnostiquer une déshydratation ?\nQuels tests pour évaluer l'équilibre hydrique ?\nQuels signes indiquent une surcharge hydrique ?\nComment détecter un déséquilibre électrolytique ?\nQuels symptômes nécessitent un diagnostic urgent ?",
"url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Proprotein+Convertase+9#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Mouvements de l'eau",
"description": "Quels sont les symptômes de la déshydratation ?\nComment reconnaître une surcharge hydrique ?\nQuels signes indiquent un déséquilibre hydrique ?\nQuels symptômes sont liés à l'hyperhydratation ?\nQuels symptômes d'un choc hypovolémique ?",
"url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Proprotein+Convertase+9#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Mouvements de l'eau",
"description": "Comment prévenir la déshydratation ?\nQuelles mesures pour éviter la surcharge hydrique ?\nComment maintenir un bon équilibre hydrique ?\nQuelles précautions pour les athlètes ?\nComment prévenir les déséquilibres électrolytiques ?",
"url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Proprotein+Convertase+9#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Mouvements de l'eau",
"description": "Comment traiter la déshydratation légère ?\nQuel traitement pour la surcharge hydrique ?\nComment gérer un déséquilibre électrolytique ?\nQuel est le traitement de l'hyperhydratation ?\nComment traiter un choc hypovolémique ?",
"url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Proprotein+Convertase+9#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Mouvements de l'eau",
"description": "Quelles complications de la déshydratation sévère ?\nQuels risques d'une surcharge hydrique prolongée ?\nQuelles complications d'un déséquilibre électrolytique ?\nQuels dangers de l'hyperhydratation ?\nQuelles complications du choc hypovolémique ?",
"url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Proprotein+Convertase+9#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Mouvements de l'eau",
"description": "Quels facteurs augmentent le risque de déshydratation ?\nQui est à risque de surcharge hydrique ?\nQuels médicaments augmentent le risque d'un déséquilibre électrolytique ?\nQuels comportements augmentent le risque d'hyperhydratation ?\nQuels facteurs de risque pour le choc hypovolémique ?",
"url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Proprotein+Convertase+9#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déshydratation ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par l'évaluation des symptômes cliniques et des tests sanguins."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer l'équilibre hydrique ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins, urinaires et des mesures de poids peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une surcharge hydrique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent œdème, hypertension et dyspnée."
}
},
{
"@type": "Question",
"name": "Comment détecter un déséquilibre électrolytique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des analyses sanguines mesurant les niveaux de sodium et potassium."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent un diagnostic urgent ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Confusion, convulsions ou perte de conscience doivent être évalués rapidement."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la déshydratation ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Soif intense, sécheresse de la peau, fatigue et urine foncée."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une surcharge hydrique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes incluent gonflement des membres, essoufflement et prise de poids rapide."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un déséquilibre hydrique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, crampes musculaires et troubles de la concentration."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à l'hyperhydratation ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Nausées, maux de tête et confusion mentale peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'un choc hypovolémique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pulsations rapides, peau froide et confusion mentale sont des indicateurs."
}
},
{
"@type": "Question",
"name": "Comment prévenir la déshydratation ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Boire régulièrement de l'eau, surtout par temps chaud ou lors d'exercices."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter la surcharge hydrique ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Limiter l'apport en liquides et surveiller les signes d'œdème."
}
},
{
"@type": "Question",
"name": "Comment maintenir un bon équilibre hydrique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consommer des aliments riches en eau et surveiller l'apport en électrolytes."
}
},
{
"@type": "Question",
"name": "Quelles précautions pour les athlètes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "S'hydrater avant, pendant et après l'exercice pour éviter la déshydratation."
}
},
{
"@type": "Question",
"name": "Comment prévenir les déséquilibres électrolytiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Avoir une alimentation équilibrée et surveiller les niveaux lors de maladies."
}
},
{
"@type": "Question",
"name": "Comment traiter la déshydratation légère ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hydratation orale avec des solutions électrolytiques est recommandée."
}
},
{
"@type": "Question",
"name": "Quel traitement pour la surcharge hydrique ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Restriction hydrique et diurétiques peuvent être prescrits."
}
},
{
"@type": "Question",
"name": "Comment gérer un déséquilibre électrolytique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments ou des modifications alimentaires peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Quel est le traitement de l'hyperhydratation ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Réduction de l'apport hydrique et administration de diurétiques."
}
},
{
"@type": "Question",
"name": "Comment traiter un choc hypovolémique ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Administration rapide de fluides intraveineux et traitement de la cause sous-jacente."
}
},
{
"@type": "Question",
"name": "Quelles complications de la déshydratation sévère ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut entraîner des lésions rénales, des convulsions et un choc hypovolémique."
}
},
{
"@type": "Question",
"name": "Quels risques d'une surcharge hydrique prolongée ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut causer un œdème pulmonaire et des troubles cardiaques."
}
},
{
"@type": "Question",
"name": "Quelles complications d'un déséquilibre électrolytique ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut entraîner des arythmies cardiaques et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels dangers de l'hyperhydratation ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut provoquer un œdème cérébral et des troubles de la conscience."
}
},
{
"@type": "Question",
"name": "Quelles complications du choc hypovolémique ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut entraîner une défaillance multi-organique et un décès si non traité."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de déshydratation ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Âge avancé, maladies chroniques et climat chaud sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Qui est à risque de surcharge hydrique ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes avec insuffisance cardiaque ou rénale sont particulièrement à risque."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent le risque d'un déséquilibre électrolytique ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les diurétiques et certains laxatifs peuvent provoquer des déséquilibres."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque d'hyperhydratation ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une consommation excessive de liquides sans équilibre électrolytique peut être risquée."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le choc hypovolémique ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Traumatismes, hémorragies et déshydratation sévère augmentent le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 18/02/2025
Contenu vérifié selon les dernières recommandations médicales
1 publication dans cette catégorie
Affiliations :
Department of Biology, Bowling Green State University, Bowling Green, OH, United States.
Great Lakes Center for Fresh Waters and Human Health, Bowling Green State University, Bowling Green, OH, United States.
Publications dans "Mouvements de l'eau" :
1 publication dans cette catégorie
Affiliations :
Great Lakes Center for Fresh Waters and Human Health, Bowling Green State University, Bowling Green, OH, United States.
Ecology and Evolutionary Biology, College of Literature, Science, and the Arts, University of Michigan, Ypsilanti, MI, United States.
Publications dans "Mouvements de l'eau" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, Bowling Green State University, Bowling Green, OH, United States.
Great Lakes Center for Fresh Waters and Human Health, Bowling Green State University, Bowling Green, OH, United States.
Publications dans "Mouvements de l'eau" :
1 publication dans cette catégorie
Affiliations :
Universidad Rey Juan Carlos, ESCET, Mostoles, 28933 Madrid, Spain.
Publications dans "Mouvements de l'eau" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, The University of Utah, Salt Lake City, Utah 84112-0850, USA.
Publications dans "Mouvements de l'eau" :
1 publication dans cette catégorie
Affiliations :
Department of Biochemistry, University of Oxford, South Parks Road, OX1 3QU Oxford, United Kingdom.
Publications dans "Mouvements de l'eau" :
1 publication dans cette catégorie
Affiliations :
Department of Biochemistry, University of Oxford, South Parks Road, OX1 3QU Oxford, United Kingdom.
Publications dans "Mouvements de l'eau" :
1 publication dans cette catégorie
Affiliations :
Universidad Complutense de Madrid, Facultad de Ciencias Fícias, Departamento de Estructura de la Materia, Física Térmica y Electrónica, 28040 Madrid, Spain.
Publications dans "Mouvements de l'eau" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, Williams College, Williamstown, MA, USA.
Publications dans "Mouvements de l'eau" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, Oberlin College, Oberlin, OH, USA.
Publications dans "Mouvements de l'eau" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, University of Massachusetts, Amherst, MA, USA.
Publications dans "Mouvements de l'eau" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, University of New Mexico, Albuquerque, NM, USA.
Publications dans "Mouvements de l'eau" :
1 publication dans cette catégorie
Affiliations :
Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Publications dans "Mouvements de l'eau" :
1 publication dans cette catégorie
Affiliations :
Department of Molecular Imaging and Theranostics, National Institutes for Quantum Science and Technology, Chiba, Japan.
Publications dans "Mouvements de l'eau" :
1 publication dans cette catégorie
Affiliations :
Department of Molecular Imaging and Theranostics, National Institutes for Quantum Science and Technology, Chiba, Japan.
Publications dans "Mouvements de l'eau" :
1 publication dans cette catégorie
Affiliations :
Department of Molecular Imaging and Theranostics, National Institutes for Quantum Science and Technology, Chiba, Japan.
Publications dans "Mouvements de l'eau" :
1 publication dans cette catégorie
Affiliations :
Department of Medical Technology, National Institutes for Quantum Science and Technology, Chiba, Japan.
Publications dans "Mouvements de l'eau" :
1 publication dans cette catégorie
Affiliations :
Department of Medical Technology, National Institutes for Quantum Science and Technology, Chiba, Japan.
Publications dans "Mouvements de l'eau" :
1 publication dans cette catégorie
Affiliations :
Department of Ophthalmology, Teikyo University, Tokyo, Japan.
Publications dans "Mouvements de l'eau" :
1 publication dans cette catégorie
Affiliations :
Department of Ophthalmology, Teikyo University, Tokyo, Japan.
Publications dans "Mouvements de l'eau" :
The gene encoding proprotein convertase subtilisin/kexin type 9 (PCSK9) and its protein product have been widely studied for their role in cholesterol and lipid metabolism. PCSK9 increases the rate of...
Although the proprotein convertase subtilisin kexin-9 inhibitors (PCSK9i) were shown to significantly lower low-density lipoprotein and reduce atherosclerotic cardiovascular disease events in clinical...
Sepsis is a life-threatening condition that arises when the body's response to infection causes injury to its tissues and organs. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is an enzyme rel...
To determine the harms of proprotein convertase subtilisin/kexin 9 (PCSK9) inhibitors in people who need lipid-lowering therapy....
This systematic review included randomised controlled trials that compared PCSK9 inhibitors with placebo, standard care or active lipid-lowering comparators in people who need lipid-lowering therapy w...
We included 32 trials with 65 861 participants (with the median follow-up duration of 40 weeks, ranging from 24 to 146 weeks). The meta-analysis showed an incidence of injection-site reaction leading ...
PCSK9 inhibitors slightly increase the risk of severe injection-site reaction but not cataracts, gastrointestinal haemorrhage, neurocognitive events, new-onset diabetes or severe myalgia or muscular p...
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a new target for reducing low-density lipoprotein cholesterol and incident cardiovascular disease, including stroke. However, the clinical rele...
In community-dwelling Japanese men (n = 526) aged 46-82 years without a history of cardiovascular disease, the associations of serum PCSK9 levels with the prevalence of CSVD and ICAS were assessed usi...
The median (interquartile range) age at baseline and serum PCSK9 levels were 69 (63-74) years and 240 (205-291) ng/ml, respectively. After adjusting for traditional cardiovascular risk factors includi...
Higher circulating PCSK9 levels were independently associated with an ICAS prevalence but not with CSVD prevalence. The quantification of circulating PCSK9 levels may help to identify individuals at h...
Proprotein convertase subtilisin/kexin type-9 (PCSK9) is a posttranslational regulator of the LDL receptor (LDLR). Recent studies have proposed a role for PCSK9 in regulating immune responses. Using R...
Guidelines advocate for intensive lipid-lowering in patients with atherosclerotic cardiovascular disease (ASCVD). In May 2020, evolocumab, a proprotein convertase subtilisin-kexin type 9 (PCSK9) inhib...
To identify barriers to prescribing PCSK9 inhibitors in hospitalised patients with ASCVD....
A retrospective 3-month, single-site, observational analysis was conducted in consecutive patients undergoing percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) surgery. L...
Of 331 patients, 244 (73.7%) underwent PCI and 87 (26.3%) underwent CABG surgery. A lipid profile during or within 8 weeks of admission was measured for 202 (82.8%) patients undergoing PCI and 59 (67....
Prescribing of non-statin LDL-C-lowering therapies remains low in patients with ASCVD. Underprescribing of ezetimibe and suboptimal lipid testing rates are barriers to accessing subsidised PCSK9i ther...
Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) levels have been suggested as novel atherosclerotic biomarker. PCSK9 plays important roles in the pathogenesis of atherosclerosis by regulating th...
This cross-sectional analysis enrolled 401 Caucasian patients with type II diabetes mellitus (T2DM). PCSK9 levels were measured by ELISA test, arterial stiffness was estimated by measuring carotid-fem...
Patients were divided in three tertiles according to increasing value of PCSK9. From the I to the III tertiles, there was a significant increase in high sensitivity C-reactive protein (hs-CRP), fibrin...
Our study demonstrates a close association between circulating PCSK9 levels and PWV in T2DM subjects without previous CV events even after adjusting for well-known CV risk factor and pharmacological m...
Proprotein convertase subtilisin/kexin-type 9 inhibitor (PCSK9i) treatment reduces cardiovascular events when taken over a long time for secondary prevention. Data on treatment adherence are scarce an...
Baseline data and prescription patterns of all 7302 patients with PCSK9i prescriptions dispensed on the account of Austrian Social Insurances between September 2015 and December 2020 were retrieved an...
Considering the high PDC and low discontinuation rates, the majority of patients adhere to PCSK9i treatment. Hence, in a system where PCSK9i treatment is made available at virtually no costs for patie...
Proprotein convertase subtilisin/kexin type 9 (PCSK9) reduces low density lipoprotein (LDL) uptake, leading to increased plasma levels of LDL. In addition, PCSK9 has been implicated in inflammation in...